From: Prospective longitudinal course of cognition in older subjects with mild parkinsonian signs
Examination | Controls | Persistent MPS | p value | |
---|---|---|---|---|
CERAD total score (0–100) | BL | 87 (64–100) | 84 (60–96) | 0.002a |
(87 ± 7) | (83 ± 8) | |||
1FU | 86 (56–100) | 82 (44–97) | 0.002a | |
(85 ± 8) | (80 ± 8) | |||
2FU | 88 (57–100) | 83 (50–98) | <0.001a | |
(87 ± 8) | (82 ± 9) | |||
TMT-A (s) | BL | 34 (15–100) | 39 (24–81) | 0.005a |
(36 ± 12) | (41 ± 12) | |||
1FU | 34 (17–103) | 41 (21–71) | 0.016a | |
(36 ± 14) | (43 ± 12) | |||
2FU | 33 (15–90) | 40 (24–110) | 0.014a | |
(36 ± 11) | (43 ± 14) | |||
TMT-B (s) | BL | 80 (34–300) | 96 (47–300) | 0.050a |
(88 ± 33) | (105 ± 40) | |||
1FU | 76 (26–300) | 93 (55–300) | <0.001a | |
(82 ± 34) | (107 ± 49) | |||
2FU | 73 (25–300) | 97 (47–300) | 0.001a | |
(81 ± 37) | (112 ± 61) | |||
TMT-B – TMT-A (s) | BL | 46 (11–185) | 54 (8–206) | 0.083a |
(52 ± 30) | (64 ± 40) | |||
1FU | 40 (5–243) | 51 (13–229) | 0.001a | |
(46 ± 29) | (64 ± 43) | |||
2FU | 39 (0–230) | 52 (19–265) | 0.004a | |
(46 ± 33) | (70 ± 54) | |||
Executive domain | BL | 0.406 ± 1.0 | 0.136 ± 1.0 | 0.288 |
1FU | 0.690 ± 1.2 | 0.215 ± 1.1 | 0.010 | |
2FU | 0.887 ± 1.3 | 0.368 ± 1.1 | 0.014 | |
Memory domain | BL | 0.002 ± 0.8 | 0.028 ± 0.8 | 0.862 |
1FU | 0.177 ± 0.8 | 0.002 ± 0.8 | 0.157 | |
2FU | 0.169 ± 0.9 | 0.124 ± 0.8 | 0.463 | |
Language domain | BL | 0.416 ± 0.7 | 0.370 ± 0.7 | 0.956 |
1FU | 0.004 ± 0.7 | −0.042 ± 0.7 | 0.575 | |
2FU | 0.343 ± 0.7 | 0.121 ± 0.7 | 0.124 | |
Visuospatial domain | BL | 0.284 ± 0.9 | 0.221 ± 1.3 | 0.073 |
1FU | 0.431 ± 0.9 | 0.074 ± 1.3 | 0.697 | |
2FU | 0.041 ± 1.0 | 0.488 ± 1.2 | 0.115 |